David Weill
Vermogen: 1 M $ op 31-05-2026
Vermogen: 1 M $ op 31-05-2026
David Weill is currently Director at TransMedics, Inc., Independent Director at TransMedics Group, Inc. since 2019, and Principal at Weill Consulting Group since 2016.
Formerly, Dr. Weill was Director at Stanford Center For Advanced Lung Diseases and Director of the Lung & Heart Lung Transplant Program at Stanford University Medical Center from 2005 to 2016.
Education includes an undergraduate degree from Tulane University (1985) and a doctorate from Tulane University School of Medicine (1990).
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-05-2026 | 15.056 ( 0,04% ) | 1 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| TRANSMEDICS GROUP, INC. | Directeur/Bestuurslid | 01-01-2019 |
Weill Consulting Group | Corporate Officer/Principal | 01-01-2016 |
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Stanford University Medical Center | Corporate Officer/Principal | 01-01-2016 |
Stanford Center For Advanced Lung Diseases | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 7 |
|---|---|
Tulane University (Louisiana)
Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Health Technology |
Tulane University School of Medicine
Tulane University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransMedics Group, Inc.
TransMedics Group, Inc. Medical SpecialtiesHealth Technology Manufactures portable electromechanical medical devices for organ transplantation of end-stage organ failure patients | Health Technology |
Weill Consulting Group | |
Stanford Center For Advanced Lung Diseases | |
Stanford University Medical Center |
Kies jouw editie
Alle financiële informatie op nationaal niveau